KPV
Animal / preclinicalAlso known as: Lysine-Proline-Valine
Community-reported ranges are anecdotal and not clinically validated. Evidence grade shown reflects the strength of available human data. Not a prescription. Legal status varies by country and changes over time; verify locally.
Overview
A tripeptide fragment of alpha-MSH studied for anti-inflammatory effects, largely in cell and animal models.
Mechanism
Proposed to reduce inflammatory signalling (e.g. NF-κB pathways); human significance unproven.
Evidence
Thin: preclinical anti-inflammatory data; no human efficacy trials.
Community-reported information
Community reports vary. Anecdotal and unvalidated; general information only.
General information only, not tailored to you and not a recommendation. Some regions withhold this entirely.
Half-life
Short.
Storage
Refrigerate solutions.
Commonly reported side effects
- Not well characterised in humans
Legal status by region
- USNot FDA-approved for human use.
Legal status changes over time; verify locally before relying on this.